penfluridol has been researched along with Autoimmune Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YH; Cui, YZ; Fu, WY; Hettinghouse, A; Liu, CJ; Liu, RH; Zhang, C; Zhang, L | 1 |
1 other study(ies) available for penfluridol and Autoimmune Disease
| Article | Year |
|---|---|
Penfluridol targets acid sphingomyelinase to inhibit TNF signaling and is therapeutic against inflammatory autoimmune diseases.
Topics: Animals; Autoimmune Diseases; Mice; NF-kappa B; Penfluridol; Sphingomyelin Phosphodiesterase; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha | 2022 |